Enhanced anti-tumor efficacy of electroporation (EP)-mediated DNA vaccine boosted by allogeneic lymphocytes in pre-established tumor models
Our preclinical studies results demonstrate an enhanced anti-tumor efficacy of EP-mediated DNA vaccination boosted with adoptively transferred, vaccinated healthy donor-derived allogeneic lymphocytes.
Authors
- Yuhong Xu (ORCID: https://orcid.org/0000-0001-5302-6392)
- Samuel Kesse (ORCID: https://orcid.org/0000-0002-6510-325X)
- Anjie Zheng
- Fang Xie (ORCID: https://orcid.org/0000-0003-2667-281X)
- Jinliang Peng (ORCID: https://orcid.org/0000-0002-1655-8389)
- Sanyuan Shi
- Luchen Zhang (ORCID: https://orcid.org/0000-0001-7682-3714)
- Yang Yang (ORCID: https://orcid.org/0000-0003-4821-0376)
Institutions
- Shanghai Jiao Tong University (CN)
- Dali University (CN)
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2024-10-03
- DOI
- https://doi.org/10.1007/s00262-024-03838-8
- Citations
- 1
- Primary Topic
- Microbial Inactivation Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- National Natural Science Foundation of China